0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-476
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Human Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-476
Report
September 2022
134 Pages
QYResearch
Region: Global, Europe, North America, Asia Pacific, Middle East
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Human Vaccine market is projected to reach US$ 44100 million by 2028 from an estimated US$ 33590 million in 2022, at a CAGR of 4.6% during 2023 and 2028.

In China, Human Vaccine key players include CNBG, Kangtai, ChengDa Bio, etc. Global top three manufacturers hold a share about 65%.

East China is the largest market, with a share about 25%, followed by South China, and North China, both have a share about 40 percent.
In terms of product, Hepatitis B is the largest segment, with a share nearly 15%. And in terms of application, the largest application is Children, followed by Adults.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Human Vaccine.
The Human Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Human Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
ZhongKe Biopharm
Zhuoyi Biological
Product Type Insights
Global markets are presented by Human Vaccine type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Human Vaccine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Human Vaccine Segment by Type

Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Human Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Human Vaccine market.

Human Vaccine Segment by Application

Adults
Children
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Human Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Human Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Human Vaccine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Vaccine

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

1 Study Coverage
1.1 Human Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Human Vaccine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Market by Application
1.3.1 Global Human Vaccine Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Vaccine Market Size Estimates and Forecasts
2.1.1 Global Human Vaccine Revenue 2017-2028
2.1.2 Global Human Vaccine Sales 2017-2028
2.2 Human Vaccine Market Size by Region: 2022 Versus 2028
2.3 Human Vaccine Sales by Region (2017-2028)
2.3.1 Global Human Vaccine Sales by Region: 2017-2022
2.3.2 Global Human Vaccine Sales Forecast by Region (2023-2028)
2.3.3 Global Human Vaccine Sales Market Share by Region (2017-2028)
2.4 Human Vaccine Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Human Vaccine Revenue by Region: 2017-2022
2.4.2 Global Human Vaccine Revenue Forecast by Region (2023-2028)
2.4.3 Global Human Vaccine Revenue Market Share by Region (2017-2028)
3 Global Human Vaccine by Manufacturers
3.1 Global Top Human Vaccine Manufacturers by Sales
3.1.1 Global Human Vaccine Sales by Manufacturer (2017-2022)
3.1.2 Global Human Vaccine Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Human Vaccine Manufacturers by Revenue
3.2.1 Global Human Vaccine Revenue by Manufacturer (2017-2022)
3.2.2 Global Human Vaccine Revenue Share by Manufacturer (2017-2022)
3.3 Global Human Vaccine Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Human Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Human Vaccine Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Human Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Human Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Human Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Human Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 CNBG
4.1.1 CNBG Corporation Information
4.1.2 CNBG Description, Business Overview
4.1.3 CNBG Human Vaccine Products Offered
4.1.4 CNBG Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.1.5 CNBG Human Vaccine Sales by Product in 2021
4.1.6 CNBG Human Vaccine Sales by Application in 2021
4.1.7 CNBG Human Vaccine Sales by Geographic Area in 2021
4.1.8 CNBG Recent Developments
4.2 Changsheng Life
4.2.1 Changsheng Life Corporation Information
4.2.2 Changsheng Life Description, Business Overview
4.2.3 Changsheng Life Human Vaccine Products Offered
4.2.4 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Changsheng Life Human Vaccine Sales by Product in 2021
4.2.6 Changsheng Life Human Vaccine Sales by Application in 2021
4.2.7 Changsheng Life Human Vaccine Sales by Geographic Area in 2021
4.2.8 Changsheng Life Recent Developments
4.3 Zhifei
4.3.1 Zhifei Corporation Information
4.3.2 Zhifei Description, Business Overview
4.3.3 Zhifei Human Vaccine Products Offered
4.3.4 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Zhifei Human Vaccine Sales by Product in 2021
4.3.6 Zhifei Human Vaccine Sales by Application in 2021
4.3.7 Zhifei Human Vaccine Sales by Geographic Area in 2021
4.3.8 Zhifei Recent Developments
4.4 ChengDa Bio
4.4.1 ChengDa Bio Corporation Information
4.4.2 ChengDa Bio Description, Business Overview
4.4.3 ChengDa Bio Human Vaccine Products Offered
4.4.4 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.4.5 ChengDa Bio Human Vaccine Sales by Product in 2021
4.4.6 ChengDa Bio Human Vaccine Sales by Application in 2021
4.4.7 ChengDa Bio Human Vaccine Sales by Geographic Area in 2021
4.4.8 ChengDa Bio Recent Developments
4.5 Kangtai
4.5.1 Kangtai Corporation Information
4.5.2 Kangtai Description, Business Overview
4.5.3 Kangtai Human Vaccine Products Offered
4.5.4 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Kangtai Human Vaccine Sales by Product in 2021
4.5.6 Kangtai Human Vaccine Sales by Application in 2021
4.5.7 Kangtai Human Vaccine Sales by Geographic Area in 2021
4.5.8 Kangtai Recent Developments
4.6 SINOVAC BIOTECH
4.6.1 SINOVAC BIOTECH Corporation Information
4.6.2 SINOVAC BIOTECH Description, Business Overview
4.6.3 SINOVAC BIOTECH Human Vaccine Products Offered
4.6.4 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.6.5 SINOVAC BIOTECH Human Vaccine Sales by Product in 2021
4.6.6 SINOVAC BIOTECH Human Vaccine Sales by Application in 2021
4.6.7 SINOVAC BIOTECH Human Vaccine Sales by Geographic Area in 2021
4.6.8 SINOVAC BIOTECH Recent Development
4.7 Hissen
4.7.1 Hissen Corporation Information
4.7.2 Hissen Description, Business Overview
4.7.3 Hissen Human Vaccine Products Offered
4.7.4 Hissen Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Hissen Human Vaccine Sales by Product in 2021
4.7.6 Hissen Human Vaccine Sales by Application in 2021
4.7.7 Hissen Human Vaccine Sales by Geographic Area in 2021
4.7.8 Hissen Recent Development
4.8 Walvax Biotechnology
4.8.1 Walvax Biotechnology Corporation Information
4.8.2 Walvax Biotechnology Description, Business Overview
4.8.3 Walvax Biotechnology Human Vaccine Products Offered
4.8.4 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Walvax Biotechnology Human Vaccine Sales by Product in 2021
4.8.6 Walvax Biotechnology Human Vaccine Sales by Application in 2021
4.8.7 Walvax Biotechnology Human Vaccine Sales by Geographic Area in 2021
4.8.8 Walvax Biotechnology Recent Development
4.9 GSK
4.9.1 GSK Corporation Information
4.9.2 GSK Description, Business Overview
4.9.3 GSK Human Vaccine Products Offered
4.9.4 GSK Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.9.5 GSK Human Vaccine Sales by Product in 2021
4.9.6 GSK Human Vaccine Sales by Application in 2021
4.9.7 GSK Human Vaccine Sales by Geographic Area in 2021
4.9.8 GSK Recent Development
4.10 SANOFI
4.10.1 SANOFI Corporation Information
4.10.2 SANOFI Description, Business Overview
4.10.3 SANOFI Human Vaccine Products Offered
4.10.4 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.10.5 SANOFI Human Vaccine Sales by Product in 2021
4.10.6 SANOFI Human Vaccine Sales by Application in 2021
4.10.7 SANOFI Human Vaccine Sales by Geographic Area in 2021
4.10.8 SANOFI Recent Development
4.11 Rong An
4.11.1 Rong An Corporation Information
4.11.2 Rong An Description, Business Overview
4.11.3 Rong An Human Vaccine Products Offered
4.11.4 Rong An Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Rong An Human Vaccine Sales by Product in 2021
4.11.6 Rong An Human Vaccine Sales by Application in 2021
4.11.7 Rong An Human Vaccine Sales by Geographic Area in 2021
4.11.8 Rong An Recent Development
4.12 NuoCheng Bio
4.12.1 NuoCheng Bio Corporation Information
4.12.2 NuoCheng Bio Description, Business Overview
4.12.3 NuoCheng Bio Human Vaccine Products Offered
4.12.4 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.12.5 NuoCheng Bio Human Vaccine Sales by Product in 2021
4.12.6 NuoCheng Bio Human Vaccine Sales by Application in 2021
4.12.7 NuoCheng Bio Human Vaccine Sales by Geographic Area in 2021
4.12.8 NuoCheng Bio Recent Development
4.13 Hualan Bio
4.13.1 Hualan Bio Corporation Information
4.13.2 Hualan Bio Description, Business Overview
4.13.3 Hualan Bio Human Vaccine Products Offered
4.13.4 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.13.5 Hualan Bio Human Vaccine Sales by Product in 2021
4.13.6 Hualan Bio Human Vaccine Sales by Application in 2021
4.13.7 Hualan Bio Human Vaccine Sales by Geographic Area in 2021
4.13.8 Hualan Bio Recent Development
4.14 Tiantan biological
4.14.1 Tiantan biological Corporation Information
4.14.2 Tiantan biological Description, Business Overview
4.14.3 Tiantan biological Human Vaccine Products Offered
4.14.4 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.14.5 Tiantan biological Human Vaccine Sales by Product in 2021
4.14.6 Tiantan biological Human Vaccine Sales by Application in 2021
4.14.7 Tiantan biological Human Vaccine Sales by Geographic Area in 2021
4.14.8 Tiantan biological Recent Development
4.15 Changchun Baike
4.15.1 Changchun Baike Corporation Information
4.15.2 Changchun Baike Description, Business Overview
4.15.3 Changchun Baike Human Vaccine Products Offered
4.15.4 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.15.5 Changchun Baike Human Vaccine Sales by Product in 2021
4.15.6 Changchun Baike Human Vaccine Sales by Application in 2021
4.15.7 Changchun Baike Human Vaccine Sales by Geographic Area in 2021
4.15.8 Changchun Baike Recent Development
4.16 Adimmune
4.16.1 Adimmune Corporation Information
4.16.2 Adimmune Description, Business Overview
4.16.3 Adimmune Human Vaccine Products Offered
4.16.4 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.16.5 Adimmune Human Vaccine Sales by Product in 2021
4.16.6 Adimmune Human Vaccine Sales by Application in 2021
4.16.7 Adimmune Human Vaccine Sales by Geographic Area in 2021
4.16.8 Adimmune Recent Development
4.17 Zhongyianke Biotech
4.17.1 Zhongyianke Biotech Corporation Information
4.17.2 Zhongyianke Biotech Description, Business Overview
4.17.3 Zhongyianke Biotech Human Vaccine Products Offered
4.17.4 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.17.5 Zhongyianke Biotech Human Vaccine Sales by Product in 2021
4.17.6 Zhongyianke Biotech Human Vaccine Sales by Application in 2021
4.17.7 Zhongyianke Biotech Human Vaccine Sales by Geographic Area in 2021
4.17.8 Zhongyianke Biotech Recent Development
4.18 Bharat Biotech
4.18.1 Bharat Biotech Corporation Information
4.18.2 Bharat Biotech Description, Business Overview
4.18.3 Bharat Biotech Human Vaccine Products Offered
4.18.4 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.18.5 Bharat Biotech Human Vaccine Sales by Product in 2021
4.18.6 Bharat Biotech Human Vaccine Sales by Application in 2021
4.18.7 Bharat Biotech Human Vaccine Sales by Geographic Area in 2021
4.18.8 Bharat Biotech Recent Development
4.19 Bavarian Nordic
4.19.1 Bavarian Nordic Corporation Information
4.19.2 Bavarian Nordic Description, Business Overview
4.19.3 Bavarian Nordic Human Vaccine Products Offered
4.19.4 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.19.5 Bavarian Nordic Human Vaccine Sales by Product in 2021
4.19.6 Bavarian Nordic Human Vaccine Sales by Application in 2021
4.19.7 Bavarian Nordic Human Vaccine Sales by Geographic Area in 2021
4.19.8 Bavarian Nordic Recent Development
4.20 Sanofi-Pasteur
4.20.1 Sanofi-Pasteur Corporation Information
4.20.2 Sanofi-Pasteur Description, Business Overview
4.20.3 Sanofi-Pasteur Human Vaccine Products Offered
4.20.4 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.20.5 Sanofi-Pasteur Human Vaccine Sales by Product in 2021
4.20.6 Sanofi-Pasteur Human Vaccine Sales by Application in 2021
4.20.7 Sanofi-Pasteur Human Vaccine Sales by Geographic Area in 2021
4.20.8 Sanofi-Pasteur Recent Development
4.21 Indian Immunologicals
4.21.1 Indian Immunologicals Corporation Information
4.21.2 Indian Immunologicals Description, Business Overview
4.21.3 Indian Immunologicals Human Vaccine Products Offered
4.21.4 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.21.5 Indian Immunologicals Human Vaccine Sales by Product in 2021
4.21.6 Indian Immunologicals Human Vaccine Sales by Application in 2021
4.21.7 Indian Immunologicals Human Vaccine Sales by Geographic Area in 2021
4.21.8 Indian Immunologicals Recent Development
4.22 KANGH
4.22.1 KANGH Corporation Information
4.22.2 KANGH Description, Business Overview
4.22.3 KANGH Human Vaccine Products Offered
4.22.4 KANGH Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.22.5 KANGH Human Vaccine Sales by Product in 2021
4.22.6 KANGH Human Vaccine Sales by Application in 2021
4.22.7 KANGH Human Vaccine Sales by Geographic Area in 2021
4.22.8 KANGH Recent Development
4.23 Henan Grand Biopharma
4.23.1 Henan Grand Biopharma Corporation Information
4.23.2 Henan Grand Biopharma Description, Business Overview
4.23.3 Henan Grand Biopharma Human Vaccine Products Offered
4.23.4 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.23.5 Henan Grand Biopharma Human Vaccine Sales by Product in 2021
4.23.6 Henan Grand Biopharma Human Vaccine Sales by Application in 2021
4.23.7 Henan Grand Biopharma Human Vaccine Sales by Geographic Area in 2021
4.23.8 Henan Grand Biopharma Recent Development
4.24 ZhongKe Biopharm
4.24.1 ZhongKe Biopharm Corporation Information
4.24.2 ZhongKe Biopharm Description, Business Overview
4.24.3 ZhongKe Biopharm Human Vaccine Products Offered
4.24.4 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.24.5 ZhongKe Biopharm Human Vaccine Sales by Product in 2021
4.24.6 ZhongKe Biopharm Human Vaccine Sales by Application in 2021
4.24.7 ZhongKe Biopharm Human Vaccine Sales by Geographic Area in 2021
4.24.8 ZhongKe Biopharm Recent Development
4.25 Zhuoyi Biological
4.25.1 Zhuoyi Biological Corporation Information
4.25.2 Zhuoyi Biological Description, Business Overview
4.25.3 Zhuoyi Biological Human Vaccine Products Offered
4.25.4 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2017-2022)
4.25.5 Zhuoyi Biological Human Vaccine Sales by Product in 2021
4.25.6 Zhuoyi Biological Human Vaccine Sales by Application in 2021
4.25.7 Zhuoyi Biological Human Vaccine Sales by Geographic Area in 2021
4.25.8 Zhuoyi Biological Recent Development
5 Breakdown Data by Type
5.1 Global Human Vaccine Sales by Type (2017-2028)
5.1.1 Global Human Vaccine Sales by Type (2017-2022)
5.1.2 Global Human Vaccine Sales Forecast by Type (2023-2028)
5.1.3 Global Human Vaccine Sales Market Share by Type (2017-2028)
5.2 Global Human Vaccine Revenue Forecast by Type (2017-2028)
5.2.1 Global Human Vaccine Revenue by Type (2017-2022)
5.2.2 Global Human Vaccine Revenue Forecast by Type (2023-2028)
5.2.3 Global Human Vaccine Revenue Market Share by Type (2017-2028)
5.3 Human Vaccine Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Human Vaccine Sales by Application (2017-2028)
6.1.1 Global Human Vaccine Sales by Application (2017-2022)
6.1.2 Global Human Vaccine Sales Forecast by Application (2023-2028)
6.1.3 Global Human Vaccine Sales Market Share by Application (2017-2028)
6.2 Global Human Vaccine Revenue Forecast by Application (2017-2028)
6.2.1 Global Human Vaccine Revenue by Application (2017-2022)
6.2.2 Global Human Vaccine Revenue Forecast by Application (2023-2028)
6.2.3 Global Human Vaccine Revenue Market Share by Application (2017-2028)
6.3 Human Vaccine Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Human Vaccine Market Size YoY Growth 2017-2028
7.2 North America Human Vaccine Market Facts & Figures by Country
7.2.1 North America Human Vaccine Sales by Country (2017-2028)
7.2.2 North America Human Vaccine Revenue by Country (2017-2028)
7.3 North America Human Vaccine Sales by Type
7.4 North America Human Vaccine Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Human Vaccine Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Human Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Human Vaccine Sales by Region (2017-2028)
8.2.2 Asia-Pacific Human Vaccine Revenue by Region (2017-2028)
8.3 Asia-Pacific Human Vaccine Sales by Type
8.4 Asia-Pacific Human Vaccine Sales by Application
9 Europe
9.1 Europe Human Vaccine Market Size YoY Growth 2017-2028
9.2 Europe Human Vaccine Market Facts & Figures by Country
9.2.1 Europe Human Vaccine Sales by Country (2017-2028)
9.2.2 Europe Human Vaccine Revenue by Country (2017-2028)
9.3 Europe Human Vaccine Sales by Type
9.4 Europe Human Vaccine Sales by Application
10 Latin America
10.1 Latin America Human Vaccine Market Size YoY Growth 2017-2028
10.2 Latin America Human Vaccine Market Facts & Figures by Country
10.2.1 Latin America Human Vaccine Sales by Country (2017-2028)
10.2.2 Latin America Human Vaccine Revenue by Country (2017-2028)
10.3 Latin America Human Vaccine Sales by Type
10.4 Latin America Human Vaccine Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Human Vaccine Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Human Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Human Vaccine Sales by Country (2017-2028)
11.2.2 Middle East and Africa Human Vaccine Revenue by Country (2017-2028)
11.3 Middle East and Africa Human Vaccine Sales by Type
11.4 Middle East and Africa Human Vaccine Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Human Vaccine Supply Chain Analysis
12.2 Human Vaccine Key Raw Materials and Upstream Suppliers
12.3 Human Vaccine Clients Analysis
12.4 Human Vaccine Sales Channel and Sales Model Analysis
12.4.1 Human Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Human Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Human Vaccine Distributors
13 Market Dynamics
13.1 Human Vaccine Industry Trends
13.2 Human Vaccine Market Drivers
13.3 Human Vaccine Market Challenges
13.4 Human Vaccine Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Human Vaccine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Manufacturers of Varicella
    Table 3. Major Manufacturers of Influenza
    Table 4. Major Manufacturers of Polio
    Table 5. Major Manufacturers of Hepatitis A
    Table 6. Major Manufacturers of Rabies
    Table 7. Major Manufacturers of BCG
    Table 8. Major Manufacturers of Hepatitis B
    Table 9. Major Manufacturers of Pertussis, Diphtheria, Tetanus
    Table 10. Major Manufacturers of Pneumococcal
    Table 11. Major Manufacturers of Rota vaccine
    Table 12. Global Human Vaccine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 13. Global Human Vaccine Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
    Table 14. Global Human Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 15. Global Human Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
    Table 16. Global Human Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 17. Global Human Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 18. Global Human Vaccine Sales by Manufacturer (2017-2022) & (M Doses)
    Table 19. Global Human Vaccine Sales Share by Manufacturer (2017-2022)
    Table 20. Human Vaccine Revenue by Manufacturer (2017-2022) & (US$ Million)
    Table 21. Human Vaccine Revenue Share by Manufacturer (2017-2022)
    Table 22. Key Manufacturers Human Vaccine Price (2017-2022) & (USD/Dose)
    Table 23. Ranking of Global Top Human Vaccine Manufacturers by Revenue (US$ Million) in 2021
    Table 24. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 25. Global Human Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Vaccine as of 2021)
    Table 26. Human Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table 27. Manufacturers Human Vaccine Product Type
    Table 28. Date of International Manufacturers Enter into Human Vaccine Market
    Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 30. CNBG Corporation Information
    Table 31. CNBG Description and Business Overview
    Table 32. CNBG Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 33. CNBG Human Vaccine Product
    Table 34. CNBG Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 35. CNBG Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 36. CNBG Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 37. CNBG Recent Development
    Table 38. Changsheng Life Corporation Information
    Table 39. Changsheng Life Description and Business Overview
    Table 40. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 41. Changsheng Life Human Vaccine Product
    Table 42. Changsheng Life Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 43. Changsheng Life Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 44. Changsheng Life Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 45. Changsheng Life Recent Development
    Table 46. Zhifei Corporation Information
    Table 47. Zhifei Description and Business Overview
    Table 48. Zhifei Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 49. Zhifei Human Vaccine Product
    Table 50. Zhifei Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 51. Zhifei Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 52. Zhifei Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 53. Zhifei Recent Development
    Table 54. ChengDa Bio Corporation Information
    Table 55. ChengDa Bio Description and Business Overview
    Table 56. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 57. ChengDa Bio Human Vaccine Product
    Table 58. ChengDa Bio Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 59. ChengDa Bio Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 60. ChengDa Bio Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 61. ChengDa Bio Recent Development
    Table 62. Kangtai Corporation Information
    Table 63. Kangtai Description and Business Overview
    Table 64. Kangtai Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 65. Kangtai Human Vaccine Product
    Table 66. Kangtai Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 67. Kangtai Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 68. Kangtai Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 69. Kangtai Recent Development
    Table 70. SINOVAC BIOTECH Corporation Information
    Table 71. SINOVAC BIOTECH Description and Business Overview
    Table 72. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 73. SINOVAC BIOTECH Human Vaccine Product
    Table 74. SINOVAC BIOTECH Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 75. SINOVAC BIOTECH Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 76. SINOVAC BIOTECH Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 77. Hissen Corporation Information
    Table 78. Hissen Description and Business Overview
    Table 79. Hissen Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 80. Hissen Human Vaccine Product
    Table 81. Hissen Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 82. Hissen Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 83. Hissen Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 84. Walvax Biotechnology Corporation Information
    Table 85. Walvax Biotechnology Description and Business Overview
    Table 86. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 87. Walvax Biotechnology Human Vaccine Product
    Table 88. Walvax Biotechnology Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 89. Walvax Biotechnology Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 90. Walvax Biotechnology Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 91. GSK Corporation Information
    Table 92. GSK Description and Business Overview
    Table 93. GSK Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 94. GSK Human Vaccine Product
    Table 95. GSK Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 96. GSK Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 97. GSK Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 98. SANOFI Corporation Information
    Table 99. SANOFI Description and Business Overview
    Table 100. SANOFI Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 101. SANOFI Human Vaccine Product
    Table 102. SANOFI Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 103. SANOFI Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 104. SANOFI Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 105. Rong An Corporation Information
    Table 106. Rong An Description and Business Overview
    Table 107. Rong An Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 108. Rong An Human Vaccine Product
    Table 109. Rong An Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 110. Rong An Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 111. Rong An Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 112. NuoCheng Bio Corporation Information
    Table 113. NuoCheng Bio Description and Business Overview
    Table 114. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 115. NuoCheng Bio Human Vaccine Product
    Table 116. NuoCheng Bio Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 117. NuoCheng Bio Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 118. NuoCheng Bio Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 119. Hualan Bio Corporation Information
    Table 120. Hualan Bio Description and Business Overview
    Table 121. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 122. Hualan Bio Human Vaccine Product
    Table 123. Hualan Bio Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 124. Hualan Bio Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 125. Hualan Bio Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 126. Tiantan biological Corporation Information
    Table 127. Tiantan biological Description and Business Overview
    Table 128. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 129. Tiantan biological Human Vaccine Product
    Table 130. Tiantan biological Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 131. Tiantan biological Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 132. Tiantan biological Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 133. Changchun Baike Corporation Information
    Table 134. Changchun Baike Description and Business Overview
    Table 135. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 136. Changchun Baike Human Vaccine Product
    Table 137. Changchun Baike Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 138. Changchun Baike Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 139. Changchun Baike Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 140. Adimmune Corporation Information
    Table 141. Adimmune Description and Business Overview
    Table 142. Adimmune Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 143. Adimmune Human Vaccine Product
    Table 144. Adimmune Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 145. Adimmune Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 146. Adimmune Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 147. Zhongyianke Biotech Corporation Information
    Table 148. Zhongyianke Biotech Description and Business Overview
    Table 149. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 150. Zhongyianke Biotech Human Vaccine Product
    Table 151. Zhongyianke Biotech Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 152. Zhongyianke Biotech Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 153. Zhongyianke Biotech Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 154. Bharat Biotech Corporation Information
    Table 155. Bharat Biotech Description and Business Overview
    Table 156. Bharat Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 157. Bharat Biotech Human Vaccine Product
    Table 158. Bharat Biotech Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 159. Bharat Biotech Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 160. Bharat Biotech Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 161. Bavarian Nordic Corporation Information
    Table 162. Bavarian Nordic Description and Business Overview
    Table 163. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 164. Bavarian Nordic Human Vaccine Product
    Table 165. Bavarian Nordic Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 166. Bavarian Nordic Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 167. Bavarian Nordic Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 168. Sanofi-Pasteur Corporation Information
    Table 169. Sanofi-Pasteur Description and Business Overview
    Table 170. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 171. Sanofi-Pasteur Human Vaccine Product
    Table 172. Sanofi-Pasteur Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 173. Sanofi-Pasteur Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 174. Sanofi-Pasteur Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 175. Indian Immunologicals Corporation Information
    Table 176. Indian Immunologicals Description and Business Overview
    Table 177. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 178. Indian Immunologicals Human Vaccine Product
    Table 179. Indian Immunologicals Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 180. Indian Immunologicals Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 181. Indian Immunologicals Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 182. KANGH Corporation Information
    Table 183. KANGH Description and Business Overview
    Table 184. KANGH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 185. KANGH Human Vaccine Product
    Table 186. KANGH Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 187. KANGH Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 188. KANGH Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 189. Henan Grand Biopharma Corporation Information
    Table 190. Henan Grand Biopharma Description and Business Overview
    Table 191. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 192. Henan Grand Biopharma Human Vaccine Product
    Table 193. Henan Grand Biopharma Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 194. Henan Grand Biopharma Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 195. Henan Grand Biopharma Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 196. ZhongKe Biopharm Corporation Information
    Table 197. ZhongKe Biopharm Description and Business Overview
    Table 198. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 199. ZhongKe Biopharm Human Vaccine Product
    Table 200. ZhongKe Biopharm Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 201. ZhongKe Biopharm Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 202. ZhongKe Biopharm Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 203. Zhuoyi Biological Corporation Information
    Table 204. Zhuoyi Biological Description and Business Overview
    Table 205. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 206. Zhuoyi Biological Human Vaccine Product
    Table 207. Zhuoyi Biological Human Vaccine Sales Proportion of Human Vaccine by Product in 2021
    Table 208. Zhuoyi Biological Human Vaccine Sales Proportion of Human Vaccine by Application in 2021
    Table 209. Zhuoyi Biological Human Vaccine Sales Proportion of Human Vaccine by Geographic Area in 2021
    Table 210. Global Human Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 211. Global Human Vaccine Sales Forecast by Type (2023-2028) & (M Doses)
    Table 212. Global Human Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 213. Global Human Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 214. Global Human Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 215. Global Human Vaccine Sales Forecast by Application (2023-2028) & (M Doses)
    Table 216. Global Human Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 217. Global Human Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 218. North America Human Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 219. North America Human Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 220. North America Human Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 221. North America Human Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 222. North America Human Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 223. North America Human Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 224. Asia-Pacific Human Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 225. Asia-Pacific Human Vaccine Sales by Region (2023-2028) & (M Doses)
    Table 226. Asia-Pacific Human Vaccine Revenue by Region (2017-2028) & (US$ Million)
    Table 227. Asia-Pacific Human Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 228. Asia-Pacific Human Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 229. Asia-Pacific Human Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 230. Europe Human Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 231. Europe Human Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 232. Europe Human Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 233. Europe Human Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 234. Europe Human Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 235. Europe Human Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 236. Latin America Human Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 237. Latin America Human Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 238. Latin America Human Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 239. Latin America Human Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 240. Latin America Human Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 241. Latin America Human Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 242. Middle East and Africa Human Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 243. Middle East and Africa Human Vaccine Sales by Country (2023-2028) & (M Doses)
    Table 244. Middle East and Africa Human Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 245. Middle East and Africa Human Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 246. Middle East and Africa Human Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 247. Middle East and Africa Human Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 248. Human Vaccine Key Raw Materials, Industry Status and Trend
    Table 249. Human Vaccine Key Raw Materials and Upstream Suppliers
    Table 250. Human Vaccine Clients Status and Trend
    Table 251. Human Vaccine Typical Clients
    Table 252. Human Vaccine Distributors
    Table 253. Human Vaccine Market Trends
    Table 254. Human Vaccine Market Drivers
    Table 255. Human Vaccine Market Challenges
    Table 256. Human Vaccine Market Restraints
    Table 257. Research Programs/Design for This Report
    Table 258. Key Data Information from Secondary Sources
    Table 259. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Vaccine Product Picture
    Figure 2. Global Human Vaccine Sales Market Share by Type in 2021 & 2028
    Figure 3. Varicella Product Picture
    Figure 4. Influenza Product Picture
    Figure 5. Polio Product Picture
    Figure 6. Hepatitis A Product Picture
    Figure 7. Rabies Product Picture
    Figure 8. BCG Product Picture
    Figure 9. Hepatitis B Product Picture
    Figure 10. Pertussis, Diphtheria, Tetanus Product Picture
    Figure 11. Pneumococcal Product Picture
    Figure 12. Global Human Vaccine Sales Market Share by Application in 2021 & 2028
    Figure 13. Adults Examples
    Figure 14. Children Examples
    Figure 15. Human Vaccine Report Years Considered
    Figure 16. Global Human Vaccine Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Human Vaccine Market Size 2017-2028 (US$ Million)
    Figure 18. Global Human Vaccine Sales 2017-2028 (M Doses)
    Figure 19. Global Human Vaccine Market Size Market Share by Region: 2022 Versus 2028
    Figure 20. Global Human Vaccine Sales Market Share Forecast by Region (2017-2028)
    Figure 21. Global Human Vaccine Revenue Market Share by Region (2017-2028)
    Figure 22. Global Human Vaccine Sales Share by Manufacturer in 2021
    Figure 23. Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 24. Global Human Vaccine Sales Market Share Forecast by Type (2017-2028)
    Figure 25. Global Human Vaccine Revenue Market Share Forecast by Type (2017-2028)
    Figure 26. Human Vaccine Average Selling Price (ASP) by Type (2017-2022) & (USD/Dose)
    Figure 27. Global Human Vaccine Sales Market Share Forecast by Application (2017-2028)
    Figure 28. Global Human Vaccine Revenue Market Share Forecast by Application (2017-2028)
    Figure 29. Human Vaccine Average Selling Price (ASP) by Application (2017-2022) & (USD/Dose)
    Figure 30. North America Human Vaccine Revenue 2017-2028 (US$ Million)
    Figure 31. North America Human Vaccine Sales Market Share by Type (2017-2022)
    Figure 32. North America Human Vaccine Sales Market Share by Application (2017-2022)
    Figure 33. Asia-Pacific Human Vaccine Revenue 2017-2028 (US$ Million)
    Figure 34. Asia-Pacific Human Vaccine Sales Market Share by Region (2017-2028)
    Figure 35. Asia-Pacific Human Vaccine Revenue Market Share by Region (2017-2028)
    Figure 36. Asia-Pacific Human Vaccine Sales Market Share by Type (2017-2022)
    Figure 37. Asia-Pacific Human Vaccine Sales Market Share by Application (2017-2022)
    Figure 38. Europe Human Vaccine Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 39. Europe Human Vaccine Sales Market Share by Country (2017-2028)
    Figure 40. Europe Human Vaccine Revenue Market Share by Country (2017-2028)
    Figure 41. Europe Human Vaccine Sales Market Share by Type (2017-2022)
    Figure 42. Europe Human Vaccine Sales Market Share by Application (2017-2022)
    Figure 43. Latin America Human Vaccine Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 44. Latin America Human Vaccine Sales Market Share by Country (2017-2028)
    Figure 45. Latin America Human Vaccine Revenue Market Share by Country (2017-2022)
    Figure 46. Latin America Human Vaccine Sales Market Share by Type (2017-2022)
    Figure 47. Latin America Human Vaccine Sales Market Share by Application (2017-2022)
    Figure 48. Middle East and Africa Human Vaccine Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 49. Middle East and Africa Human Vaccine Sales Market Share by Country (2017-2028)
    Figure 50. Middle East and Africa Human Vaccine Revenue Market Share by Country (2017-2028)
    Figure 51. Middle East and Africa Human Vaccine Sales Market Share by Type (2017-2022)
    Figure 52. Middle East and Africa Human Vaccine Sales Market Share by Application (2017-2022)
    Figure 53. Human Vaccine Supply Chain (Upstream and Downstream Market)
    Figure 54. Global Production Market Share of Human Vaccine Raw Materials by Region in 2021
    Figure 55. Human Vaccine Distribution Channels
    Figure 56. Global Human Vaccine Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 57. Global Human Vaccine Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD
SIMILAR REPORTS